These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 34725650)

  • 1. The severity of SARS-CoV-2 infection is dictated by host factors? Epigenetic perspectives.
    Sethumadhavan DV; Jabeena CA; Govindaraju G; Soman A; Rajavelu A
    Curr Res Microb Sci; 2021 Dec; 2():100079. PubMed ID: 34725650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of host epigenome by coronavirus infections and developing treatment modalities for COVID-19 beyond genetics.
    Rabaan AA; Al Mutair A; Alhumaid S; Al Alawi Z; Al Mohaini M; Alsalman AJ; Fawzy M; Al-Tawfiq JA; Almahmoud S; Alfouzan W; Bilal M; Dhawan M; Mohapatra RK; Tiwari R; Khan Z; Mitra S; Emran TB; Dhama K
    Eur Rev Med Pharmacol Sci; 2021 Oct; 25(19):5947-5964. PubMed ID: 34661254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.
    Bello-Chavolla OY; Bahena-López JP; Antonio-Villa NE; Vargas-Vázquez A; González-Díaz A; Márquez-Salinas A; Fermín-Martínez CA; Naveja JJ; Aguilar-Salinas CA
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32474598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of morbidity and mortality in COVID-19.
    Gacche RN; Gacche RA; Chen J; Li H; Li G
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1684-1707. PubMed ID: 33629339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»).
    Tarlovskaya EI; Arutyunov AG; Konradi AO; Lopatin YM; Rebrov AP; Tereshchenko SN; Chesnikova AI; Hayrapetyan HG; Babin AP; Bakulin IG; Bakulina NV; Balykova LA; Blagonravova AS; Boldina MV; Vaisberg AR; Galyavich AS; Gomonova VV; Grigorieva NY; Gubareva IV; Demko IV; Evzerikhina AV; Zharkov AV; Kamilova UK; Kim ZF; Kuznetsova TY; Lareva NV; Makarova EV; Malchikova SV; Nedogoda SV; Petrova MM; Pochinka IG; Protasov KV; Protsenko DN; Ruzanau DY; Sayganov SA; Sarybaev AS; Selezneva NM; Sugraliev AB; Fomin IV; Khlynova OV; Chizhova OY; Shaposhnik II; Shсukarev DA; Abdrahmanova AK; Avetisian SA; Avoyan HG; Azarian KK; Aimakhanova GT; Ayipova DA; Akunov AC; Alieva MK; Aparkina AV; Aruslanova OR; Ashina EY; Badina OY; Barisheva OY; Batchayeva AS; Bitieva AM; Bikhteyev IU; Borodulina NA; Bragin MV; Budu AM; Burygina LA; Bykova GA; Vagapova KR; Varlamova DD; Vezikova NN; Verbitskaya EA; Vilkova OE; Vinnikova EA; Vustina VV; Gаlova EA; Genkel VV; Gorshenina EI; Gostishev RV; Grigorieva EV; Gubareva EY; Dabylova GM; Demchenko AI; Dolgikh OY; Duyshobayev MY; Evdokimov DS; Egorova KE; Ermilova AN; Zheldybayeva AE; Zarechnova NV; Zimina YD; Ivanova SY; Ivanchenko EY; Ilina MV; Kazakovtseva MV; Kazymova EV; Kalinina YS; Kamardina NA; Karachenova AM; Karetnikov IA; Karoli NA; Karpov OV; Karsiev MK; Кaskaeva DS; Kasymova KF; Kerimbekova ZB; Kerimova AS; Kim ES; Kiseleva NV; Klimenko DA; Klimova AV; Kovalishena OV; Kolmakova EV; Kolchinskaya TP; Kolyadich MI; Kondriakova OV; Konoval MP; Konstantinov DY; Konstantinova EA; Kordukova VA; Koroleva EV; Kraposhina AY; Kriukova TV; Kuznetsova AS; Kuzmina TY; Kuzmichev KV; Kulchoroeva CK; Kuprina TV; Kouranova IM; Kurenkova LV; Kurchugina NY; Kushubakova NA; Levankova VI; Levin MЕ; Lyubavina NA; Magdeyeva NA; Mazalov KV; Majseenko VI; Makarova AS; Maripov AM; Marusina AA; Melnikov ES; Moiseenko NB; Muradova FN; Muradyan RG; Myshak AO; Nikitina NM; Ogurlieva BB; Odegova AA; Omarova YM; Omurzakova NA; Ospanova SO; Pahomova EV; Petrov LD; Plastinina SS; Pogrebetskaya VA; Polyakov DS; Ponomarenko EV; Popova LL; Prokofeva NA; Pudova IA; Rakov NA; Rakhimov AN; Rozanova NA; Serikbolkyzy S; Simonov AA; Skachkova VV; Soloveva DV; Soloveva IA; Sokhova FM; Subbotin AK; Sukhomlinova IM; Sushilova AG; Tagayeva DR; Titojkina YV; Tikhonova EP; Tokmin DS; Tolmacheva AA; Torgunakova MS; Trenogina KV; Trostianetckaia NA; Trofimov DA; Tulichev AA; Tursunova AT; Ulanova ND; Fatenkov OV; Fedorishina OV; Fil TS; Fomina IY; Fominova IS; Frolova IA; Tsvinger SM; Tsoma VV; Cholponbaeva MB; Chudinovskikh TI; Shevchenko OA; Sheshina TV; Shishkina EA; Shishkov KY; Sherbakov SY; Yausheva EA; Musaelian SN; Belenkov YN; Arutyunov GP
    Kardiologiia; 2021 Sep; 61(9):20-32. PubMed ID: 34713782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
    Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
    Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic Regulator miRNA Pattern Differences Among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide Isolates Delineated the Mystery Behind the Epic Pathogenicity and Distinct Clinical Characteristics of Pandemic COVID-19.
    Khan MA; Sany MRU; Islam MS; Islam ABMMK
    Front Genet; 2020; 11():765. PubMed ID: 32765592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.
    Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B
    J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Companion animals likely do not spread COVID-19 but may get infected themselves.
    Csiszar A; Jakab F; Valencak TG; Lanszki Z; Tóth GE; Kemenesi G; Tarantini S; Fazekas-Pongor V; Ungvari Z
    Geroscience; 2020 Oct; 42(5):1229-1236. PubMed ID: 32766998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenome-wide association study of COVID-19 severity with respiratory failure.
    Castro de Moura M; Davalos V; Planas-Serra L; Alvarez-Errico D; Arribas C; Ruiz M; Aguilera-Albesa S; Troya J; Valencia-Ramos J; Vélez-Santamaria V; Rodríguez-Palmero A; Villar-Garcia J; Horcajada JP; Albu S; Casasnovas C; Rull A; Reverte L; Dietl B; Dalmau D; Arranz MJ; Llucià-Carol L; Planas AM; Pérez-Tur J; Fernandez-Cadenas I; Villares P; Tenorio J; Colobran R; Martin-Nalda A; Soler-Palacin P; Vidal F; Pujol A; Esteller M
    EBioMedicine; 2021 Apr; 66():103339. PubMed ID: 33867313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
    Yin T; Li Y; Ying Y; Luo Z
    BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
    Ge E; Li Y; Wu S; Candido E; Wei X
    PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing a two-pronged epidemic in Mexico of non-communicable diseases and SARS-Cov-2: factors associated with increased case-fatality rates.
    Monterrubio-Flores E; Ramírez-Villalobos MD; Espinosa-Montero J; Hernandez B; Barquera S; Villalobos-Daniel VE; Campos-Nonato I
    Int J Epidemiol; 2021 May; 50(2):430-445. PubMed ID: 33585901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Infection in a Spanish Cohort of CKD-5D Patients: Prevalence, Clinical Presentation, Outcomes, and De-Isolation Results.
    Broseta JJ; Rodríguez-Espinosa D; Cuadrado E; Guillén-Olmos E; Hermida E; Montagud-Marrahi E; Rodas L; Vera M; Fontseré N; Arias M; Cases A; Maduell F
    Blood Purif; 2021; 50(4-5):531-538. PubMed ID: 33352569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors of Infection, Hospitalization and Death from SARS-CoV-2: A Population-Based Cohort Study.
    Castilla J; Guevara M; Miqueleiz A; Baigorria F; Ibero-Esparza C; Navascués A; Trobajo-Sanmartín C; Martínez-Baz I; Casado I; Burgui C; Ezpeleta C; The Working Group For The Study Of Covid-In Navarra
    J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34199198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic mechanisms influencing COVID-19.
    Sen R; Garbati M; Bryant K; Lu Y
    Genome; 2021 Apr; 64(4):372-385. PubMed ID: 33395363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence and Re-emergence of Human Coronaviruses: Spike Protein as the Potential Molecular Switch and Pharmaceutical Target.
    Ahmad F; Kamal MA; Tekwani BL
    Curr Pharm Des; 2021; 27(33):3566-3576. PubMed ID: 33327904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis.
    Ng WH; Tipih T; Makoah NA; Vermeulen JG; Goedhals D; Sempa JB; Burt FJ; Taylor A; Mahalingam S
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisiting pulmonary rehabilitation during COVID-19 pandemic: a narrative review.
    Dixit S; Borghi-Silva A; Bairapareddy KC
    Rev Cardiovasc Med; 2021 Jun; 22(2):315-327. PubMed ID: 34258900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis.
    Salter A; Fox RJ; Newsome SD; Halper J; Li DKB; Kanellis P; Costello K; Bebo B; Rammohan K; Cutter GR; Cross AH
    JAMA Neurol; 2021 Jun; 78(6):699-708. PubMed ID: 33739362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.